Biovyta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 287,559 | 128,982 | 32,279 | 10,676 | 12,750 | 1,032 | 860 | 2,000 |
| Profit before tax | -8,343 | 2,818 | -13,230 | 10,936 | 6,823 | -14,149 | -4,777 | -3,858 |
| Net profit | -8,343 | 2,818 | -13,230 | 10,936 | 6,823 | -14,149 | -4,777 | -3,858 |
| Equity | 13,427 | 16,196 | 2,967 | 14,883 | 21,706 | 7,557 | 2,780 | -1,078 |
| Liabilities | 63,403 | 45,214 | 40,792 | 17,894 | 16,114 | 11,935 | 16,174 | 20,460 |
| Non-current assets | 10,076 | 16,019 | 16,308 | 3,380 | 1,793 | 345 | 1 | 1 |
| Current assets | 66,720 | 45,391 | 27,451 | 29,397 | 36,027 | 19,147 | 18,953 | 19,381 |
| Total assets | 76,796 | 61,410 | 43,759 | 32,777 | 37,820 | 19,492 | 18,954 | 19,382 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 650 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -22.6% | -55.1% | -75.0% | -66.9% | +19.4% | -91.9% | -16.7% | +132.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -10.9% | 4.6% | -30.2% | 33.4% | 18.0% | -72.6% | -25.2% | -19.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -62.1% | 17.4% | -445.9% | 73.5% | 31.4% | -187.2% | -171.8% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2.9% | 2.2% | -41.0% | 102.4% | 53.5% | -1371.0% | -555.5% | -192.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -2.9% | 2.2% | -41.0% | 102.4% | 53.5% | -1371.0% | -555.5% | -192.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.7 | 2.8 | 13.7 | 1.2 | 0.7 | 1.6 | 5.8 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 143,780 | 61,912 | 17,607 | 10,676 | 12,750 | 1,032 | 860 | 2,000 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biovyta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 31.37 |
| 2026-08-19 | 2026-08-19 | 31.37 |
| 2026-07-19 | 2026-08-09 | 31.37 |
| 2026-07-16 | 2026-07-17 | 31.37 |
| 2026-02-18 | 2026-02-22 | 38.81 |
| 2026-01-21 | 2026-01-22 | 48.60 |
| 2026-01-16 | 2026-01-20 | 47.81 |
| 2026-01-01 | 2026-01-15 | 9.47 |
| 2025-12-16 | 2025-12-30 | 9.47 |
| 2025-11-18 | 2025-12-15 | 61.61 |
| 2025-10-31 | 2025-11-17 | 28.51 |
| 2025-10-27 | 2025-10-30 | 32.69 |
| 2025-10-26 | 2025-10-26 | 32.50 |
| 2025-10-23 | 2025-10-25 | 32.69 |
| 2025-10-16 | 2025-10-22 | 32.50 |
| 2025-09-16 | 2025-09-24 | 38.08 |
| 2025-07-24 | 2025-08-18 | 0.06 |
| 2025-07-16 | 2025-07-22 | 38.07 |
| 2025-06-17 | 2025-06-19 | 35.62 |
| 2025-04-16 | 2025-04-16 | 37.58 |
| 2025-03-18 | 2025-03-19 | 50.48 |
| 2025-02-18 | 2025-02-20 | 46.13 |
| 2024-12-17 | 2024-12-17 | 33.86 |
| 2024-11-18 | 2024-11-20 | 23.81 |
| 2024-10-16 | 2024-10-20 | 37.58 |
| 2024-09-17 | 2024-09-22 | 16.56 |
| 2024-08-19 | 2024-08-22 | 24.53 |
| 2024-05-16 | 2024-06-13 | 0.92 |
| 2024-01-23 | 2024-03-17 | 0.03 |
| 2023-11-16 | 2023-12-14 | 0.60 |
| 2023-10-27 | 2023-11-14 | 0.01 |
| 2023-10-25 | 2023-10-25 | 0.01 |
| 2023-10-17 | 2023-10-17 | 29.47 |
| 2023-08-17 | 2023-09-14 | 0.63 |
| 2023-02-17 | 2023-03-15 | 0.01 |
| 2023-02-06 | 2023-02-13 | 0.01 |
| 2023-01-23 | 2023-02-03 | 0.01 |
| 2022-05-17 | 2022-06-14 | 0.01 |
| 2022-04-25 | 2022-05-12 | 0.01 |
Biovyta - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.